Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors
Main Authors: | Anders, Carey K., Acharya, Chaitanya R., Hsu, David S., Broadwater, Gloria, Garman, Katherine, Foekens, John A., Zhang, Yi, Wang, Yixin, Marcom, Kelly, Marks, Jeffrey R., Mukherjee, Sayan, Nevins, Joseph R., Blackwell, Kimberly L., Potti, Anil |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2008
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148101/ |
Similar Items
-
Retraction: An Integrated Approach to the Prediction of
Chemotherapeutic Response in Patients with Breast Cancer
by: Salter, Kelly H., et al.
Published: (2011) -
Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer
by: Bild, Andrea H, et al.
Published: (2011) -
Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer
by: Alkarain, Angel, et al.
Published: (2004) -
Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs
by: Mori, Seiichi, et al.
Published: (2009) -
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2
by: Morse, Michael A, et al.
Published: (2007)